Brief: Spago Nanomedical Q3 Loss Widens To SEK 10.1 Mln
Nov 10 (Reuters) - Spago Nanomedical AB (publ) SPAGO.ST :
* SPAGO NANOMEDICAL INTERIM REPORT JANUARY-SEPTEMBER 2021
* Q3 LOSS FOR QUARTER AMOUNTED TO KSEK -10,103 (KSEK
-4,485).
* Q3 NET SALES SEK 0.2 MILLION VERSUS SEK 67,000 YEAR AGO
Source text for Eikon: ID:nMFN6QB6Tt
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose